MDCE's $2.54 Million Memorabilia Acquisition Fuels AI Healthcare Ambitions

Los Angeles, Thursday, 11 September 2025.
Infinite Auctions secures high-value sports memorabilia, including a $1M LeBron jersey, to support MDCE’s AI-driven healthcare platform and enhance financial flexibility for R&D.
Strategic Acquisition to Boost Financial Health
Medical Care Technologies Inc. (OTC Pink: MDCE) has strategically bolstered its financial standing with the acquisition of high-value sports memorabilia through its subsidiary, Infinite Auctions LLC. This $2.54 million inventory includes a LeBron James 2016 NBA Finals game-worn jersey, valued at nearly $1 million, and a rare Tom Brady 1/1 card, which could fetch hundreds of thousands of dollars in the market [1][2].
Enhancing AI Healthcare Development
The acquisition is not just an investment in sports memorabilia but a calculated move to enhance the development of MDCE’s AI-driven healthcare platform. The financial flexibility afforded by these high-value assets supports research and development in areas such as mental health tracking, wound monitoring, and melanoma detection [1][3]. By leveraging these assets, MDCE aims to accelerate the commercialization of its AI healthcare solutions [2][3].
Market Synergy and Long-Term Vision
This acquisition highlights the synergy between MDCE’s pursuit of innovation in healthcare and the booming sports memorabilia market, which was valued at $26.1 billion in 2021 and is projected to exceed $40 billion by 2030 [1][2]. The company is not only enhancing its revenue streams through memorabilia but also reinforcing its commitment to pioneering healthcare technologies that could transform preventive medicine [3].
CEO’s Vision and Future Prospects
Marshall Perkins, CEO of MDCE, emphasized the dual focus on expanding value in both sports memorabilia and healthcare innovation. The infusion of liquidity from memorabilia sales is intended to bolster MDCE’s balance sheet, providing the financial flexibility necessary for advancing its AI healthcare technologies and potentially saving lives through earlier detection of chronic and life-threatening conditions [2][3].